We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients.
- Authors
Stein, Murray B; Kerridge, Carol; Dimsdale, Joel E; Hoyt, David B
- Abstract
Acute physical injury is frequently associated with mental health sequelae, which then accentuate disability and worsen functional outcomes. A pharmacological prevention approach to this problem has been proposed. This proof-of-concept study was a double-blind, randomized controlled trial of 14 days of the beta-blocker propranolol (n = 17), the anxiolytic anticonvulsant gabapentin (n = 14), or placebo (n = 17), administered within 48 hours of injury to patients admitted to a surgical trauma center. Of 569 accessible, potentially eligible subjects, 48 (8%) participated. Outcomes assessments were conducted at 1, 4, and 8 months postinjury. Although well tolerated, neither study drug showed a significant benefit over placebo on depressive or posttraumatic stress symptoms. Implications are discussed for future pharmacological prevention studies in survivors of acute traumatic injury.
- Publication
Journal of traumatic stress, 2007, Vol 20, Issue 6, p923
- ISSN
0894-9867
- Publication type
Journal Article
- DOI
10.1002/jts.20270